Switch to List View
Image and Video Gallery
This is a searchable collection of scientific photos, illustrations, and videos. The images and videos in this gallery are licensed under Creative Commons Attribution Non-Commercial ShareAlike 3.0. This license lets you remix, tweak, and build upon this work non-commercially, as long as you credit and license your new creations under identical terms.
2796: Anti-tumor drug ecteinascidin 743 (ET-743), structure without hydrogens 03
2796: Anti-tumor drug ecteinascidin 743 (ET-743), structure without hydrogens 03
Ecteinascidin 743 (ET-743, brand name Yondelis), was discovered and isolated from a sea squirt, Ecteinascidia turbinata, by NIGMS grantee Kenneth Rinehart at the University of Illinois. It was synthesized by NIGMS grantees E.J. Corey and later by Samuel Danishefsky. Multiple versions of this structure are available as entries 2790-2797.
Timothy Jamison, Massachusetts Institute of Technology
View Media
1265: Glycan arrays
1265: Glycan arrays
The signal is obtained by allowing proteins in human serum to interact with glycan (polysaccharide) arrays. The arrays are shown in replicate so the pattern is clear. Each spot contains a specific type of glycan. Proteins have bound to the spots highlighted in green.
Ola Blixt, Scripps Research Institute
View Media
3414: X-ray co-crystal structure of Src kinase bound to a DNA-templated macrocycle inhibitor 2
3414: X-ray co-crystal structure of Src kinase bound to a DNA-templated macrocycle inhibitor 2
X-ray co-crystal structure of Src kinase bound to a DNA-templated macrocycle inhibitor. Related to 3413, 3415, 3416, 3417, 3418, and 3419.
Markus A. Seeliger, Stony Brook University Medical School and David R. Liu, Harvard University
View Media
6767: Space-filling model of a cefotaxime-CCD-1 complex
6767: Space-filling model of a cefotaxime-CCD-1 complex
CCD-1 is an enzyme produced by the bacterium Clostridioides difficile that helps it resist antibiotics. Using X-ray crystallography, researchers determined the structure of a complex between CCD-1 and the antibiotic cefotaxime (purple, yellow, and blue molecule). The structure revealed that CCD-1 provides extensive hydrogen bonding (shown as dotted lines) and stabilization of the antibiotic in the active site, leading to efficient degradation of the antibiotic.
Related to images 6764, 6765, and 6766.
Related to images 6764, 6765, and 6766.
Keith Hodgson, Stanford University.
View Media
5752: Genetically identical mycobacteria respond differently to antibiotic 2
5752: Genetically identical mycobacteria respond differently to antibiotic 2
Antibiotic resistance in microbes is a serious health concern. So researchers have turned their attention to how bacteria undo the action of some antibiotics. Here, scientists set out to find the conditions that help individual bacterial cells survive in the presence of the antibiotic rifampicin. The research team used Mycobacterium smegmatis, a more harmless relative of Mycobacterium tuberculosis, which infects the lung and other organs to cause serious disease.
In this video, genetically identical mycobacteria are growing in a miniature growth chamber called a microfluidic chamber. Using live imaging, the researchers found that individual mycobacteria will respond differently to the antibiotic, depending on the growth stage and other timing factors. The researchers used genetic tagging with green fluorescent protein to distinguish cells that can resist rifampicin and those that cannot. With this gene tag, cells tolerant of the antibiotic light up in green and those that are susceptible in violet, enabling the team to monitor the cells' responses in real time.
To learn more about how the researchers studied antibiotic resistance in mycobacteria, see this news release from Tufts University. Related to image 5751.
In this video, genetically identical mycobacteria are growing in a miniature growth chamber called a microfluidic chamber. Using live imaging, the researchers found that individual mycobacteria will respond differently to the antibiotic, depending on the growth stage and other timing factors. The researchers used genetic tagging with green fluorescent protein to distinguish cells that can resist rifampicin and those that cannot. With this gene tag, cells tolerant of the antibiotic light up in green and those that are susceptible in violet, enabling the team to monitor the cells' responses in real time.
To learn more about how the researchers studied antibiotic resistance in mycobacteria, see this news release from Tufts University. Related to image 5751.
Bree Aldridge, Tufts University
View Media
6802: Antibiotic-surviving bacteria
6802: Antibiotic-surviving bacteria
Colonies of bacteria growing despite high concentrations of antibiotics. These colonies are visible both by eye, as seen on the left, and by bioluminescence imaging, as seen on the right. The bioluminescent color indicates the metabolic activity of these bacteria, with their red centers indicating high metabolism.
More information about the research that produced this image can be found in the Antimicrobial Agents and Chemotherapy paper “Novel aminoglycoside-tolerant phoenix colony variants of Pseudomonas aeruginosa” by Sindeldecker et al.
More information about the research that produced this image can be found in the Antimicrobial Agents and Chemotherapy paper “Novel aminoglycoside-tolerant phoenix colony variants of Pseudomonas aeruginosa” by Sindeldecker et al.
Paul Stoodley, The Ohio State University.
View Media